A man from Columbia, Missouri, got a new heart and a second chance at life, marking the 1,000th heart transplant at Saint Luke's Mid America Heart Institute.
Semaglutide improved symptoms, physical limitations, and exercise capacity in patients with obesity and heart failure across the spectrum of left ventricular ejection fraction.